Clinical Trials Directory

Trials / Sponsors / Criterium, Inc.

Criterium, Inc.

Industry · 13 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory
Colorectal Cancer
Phase 22025-10-27
RecruitingTucatinib+Trastuzumab+Eribulin in HER2+ MBC
Breast Cancer, Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer
Phase 22024-01-30
Active Not RecruitingClinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.
HER2-positive Metastatic Breast Cancer
Phase 1 / Phase 22022-08-25
WithdrawnA Phase I/II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic
Non Small Cell Lung Cancer
Phase 1 / Phase 22022-06-15
TerminatedCNS Dose Escalation/Expansion of Tepotinib in MET-driven NSCLC
Advanced Non-Small Cell Lung Cancer With MET Mutations
Phase 1 / Phase 22022-05-25
TerminatedPhase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Can
Breast Cancer
Phase 1 / Phase 22022-04-21
RecruitingDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Bre
Breast Cancer
Phase 22021-02-09
UnknownFOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Colorectal Cancer Metastatic
Phase 22019-12-02
TerminatedTrial of Brigatinib After Treatment With Next-Generation ALK Inhibitors
Non-Small Cell Lung Cancer
Phase 22017-03-09
TerminatedStudy of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Colorectal Adenocarcinoma, Cholangiocarcinoma, Pancreatic Adenocarcinoma
Phase 22015-12-01
CompletedA Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
Amyloidosis, Systemic Light Chain Amyloidosis
Phase 12013-02-01
CompletedA Safety Study of Carfilzomib, Cyclophosphamide & Dexamethasone Prior to ASCT in Patients With Newly Diagnosed
Multiple Myeloma
Phase 12013-01-01
TerminatedA Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Re
Multiple Myeloma
Phase 1 / Phase 22011-11-01